Instituto Portugues de Oncologia do Porto Francisco Gentil /ID# 279702

Porto 4200-072

1 studies enrolling now · 1 studies all time

What they study most

Colorectal Cancer

Studies at this site

• A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer — Recruiting now